Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Brief Report: The Genetic Profile of Rheumatoid Factor-Positive Polyarticular Juvenile Idiopathic Arthritis Resembles That of Adult Rheumatoid Arthritis.

Authors:
Anne Hinks Miranda C Marion Joanna Cobb Mary E Comeau Marc Sudman Hannah C Ainsworth John Bowes Mara L Becker John F Bohnsack Johannes-Peter Haas Daniel J Lovell Elizabeth D Mellins J Lee Nelson Ellen Nordal Marilynn Punaro Ann M Reed Carlos D Rose Alan M Rosenberg Marite Rygg Samantha L Smith Anne M Stevens Vibeke Videm Carol A Wallace Lucy R Wedderburn Annie Yarwood Rae S M Yeung Carl D Langefeld Susan D Thompson Wendy Thomson Sampath Prahalad

Arthritis Rheumatol 2018 06 21;70(6):957-962. Epub 2018 Apr 21.

Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, Georgia.

Objective: Juvenile idiopathic arthritis (JIA) comprises 7 heterogeneous categories of chronic childhood arthritides. Approximately 5% of children with JIA have rheumatoid factor (RF)-positive arthritis, which phenotypically resembles adult rheumatoid arthritis (RA). Our objective was to compare and contrast the genetics of RF-positive polyarticular JIA with those of RA and selected other JIA categories, to more fully understand the pathophysiologic relationships of inflammatory arthropathies.

Methods: Patients with RF-positive polyarticular JIA (n = 340) and controls (n = 14,412) were genotyped using the Immunochip array. Single-nucleotide polymorphisms were tested for association using a logistic regression model adjusting for admixture proportions. We calculated weighted genetic risk scores (wGRS) of reported RA and JIA risk loci, and we compared the ability of these wGRS to predict RF-positive polyarticular JIA.

Results: As expected, the HLA region was strongly associated with RF-positive polyarticular JIA (P = 5.51 × 10 ). Nineteen of 44 RA risk loci and 6 of 27 oligoarticular/RF-negative polyarticular JIA risk loci were associated with RF-positive polyarticular JIA (P < 0.05). The RA wGRS predicted RF-positive polyarticular JIA (area under the curve [AUC] 0.71) better than did the oligoarticular/RF-negative polyarticular JIA wGRS (AUC 0.59). The genetic profile of patients with RF-positive polyarticular JIA was more similar to that of RA patients with age at onset 16-29 years than to that of RA patients with age at onset ≥70 years.

Conclusion: RF-positive polyarticular JIA is genetically more similar to adult RA than to the most common JIA categories and thus appears to be a childhood-onset presentation of autoantibody-positive RA. These findings suggest common disease mechanisms, which could lead to novel therapeutic targets and shared treatment strategies.

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.40443DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984672PMC
June 2018

Publication Analysis

Top Keywords

polyarticular jia
36
rf-positive polyarticular
32
jia
14
risk loci
12
polyarticular
11
rf-positive
9
resembles adult
8
rheumatoid arthritis
8
adult rheumatoid
8
jia categories
8
jia risk
8
oligoarticular/rf-negative polyarticular
8
arthritis objective
8
idiopathic arthritis
8
age onset
8
patients age
8
associated rf-positive
8
juvenile idiopathic
8
patients rf-positive
8
genetic profile
8

Altmetric Statistics


Show full details
24 Total Shares
22 Tweets
22 Citations

Similar Publications

Prevalence and significance of serum 14-3-3η in juvenile idiopathic arthritis.

Authors:
Iris Reyhan Olga S Zhukov Robert J Lagier Robert F Bridgforth Gary J Williams Joanna M Popov Stanley J Naides Andreas Reiff

Pediatr Rheumatol Online J 2021 Feb 16;19(1):14. Epub 2021 Feb 16.

University of Southern California-Children's Hospital of Los Angeles, 4650 Sunset Blvd. Mailstop #60, Los Angeles, CA, 90027, USA.

Background: Prompt diagnosis of juvenile idiopathic arthritis (JIA) is important to avoid long term complications. Elevated serum 14-3-3η levels improve the diagnostic sensitivity of rheumatoid factor (RF) and cyclic citrullinated peptide (CCP) antibody in adult rheumatoid arthritis (RA), and have been associated with more severe phenotype. We investigated the prevalence and clinical significance of serum 14-3-3η in different types of JIA. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

The quality of life in Chinese juvenile idiopathic arthritis patients: psychometric properties of the pediatric quality of life inventor generic core scales and rheumatology module.

Authors:
Hua-Hong Wu Feng-Qi Wu Yang Li Jian-Ming Lai Gai-Xiu Su Shu-Hua Cui Zheng Chen Hui Li

Health Qual Life Outcomes 2021 Jan 30;19(1):37. Epub 2021 Jan 30.

Department of Growth and Development, Capital Institute of Pediatrics, YaBao Road, ChaoYang District, Beijing, 100020, China.

Background: Juvenile idiopathic arthritis (JIA) may seriously affects patients' quality of life (QoL), but it was rarely focused and studied in China, so we explore JIA children's QoL using Chinese version of the PedsQL4.0 Generic Core and PedsQL3.0 Rheumatology Module scale, and analyzed the psychometric properties of these two Scales among Chinese JIA children. Read More

View Article and Full-Text PDF
January 2021
Similar Publications

Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis.

Authors:
Nicolino Ruperto Hermine I Brunner Athimalaipet V Ramanan Gerd Horneff Rubén Cuttica Michael Henrickson Jordi Anton Alina Lucica Boteanu Inmaculada Calvo Penades Kirsten Minden Heinrike Schmeling Markus Hufnagel Jennifer E Weiss Manuela Pardeo Kabita Nanda Johannes Roth Nadina Rubio-Pérez Joy C Hsu Sunethra Wimalasundera Chris Wells Kamal Bharucha Wendy Douglass Min Bao Navita L Mallalieu Alberto Martini Daniel Lovell Fabrizio De Benedetti

Rheumatology (Oxford) 2021 Jan 28. Epub 2021 Jan 28.

Division of Rheumatology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy.

Objectives: To determine subcutaneous-tocilizumab (SC-TCZ) dosing regimens for systemic juvenile idiopathic arthritis (sJIA) and polyarticular JIA (pJIA).

Methods: In two 52-week phase 1 b trials, SC-TCZ (162 mg/dose) was administered to sJIA patients every week or every 2 weeks (every 10 days before interim analysis) and to pJIA patients every 2 weeks or every 3 weeks with body weight ≥30 kg or < 30 kg, respectively. Primary endpoints were pharmacokinetics, pharmacodynamics and safety; efficacy was exploratory. Read More

View Article and Full-Text PDF
January 2021
Similar Publications

14-3-3 Protein as a Potential Biomarker in Juvenile Idiopathic Arthritis.

Authors:
Austin Dalrymple Paul Tuttle Lance Feller Olga Zhukov Robert Lagier Joanna Popov Stanley Naides Terry Moore

Pediatr Rep 2021 Jan 25;13(1):65-71. Epub 2021 Jan 25.

Division of Adult & Pediatric Rheumatology, Saint Louis University School of Medicine & SSM Health Cardinal Glennon Children's Hospital, Saint Louis, MO 63104, USA.

The 14-3-3 (eta) protein was evaluated as a biomarker in a cohort of patients with juvenile idiopathic arthritis (JIA), as well as disease- and healthy-controls, to determine its potential clinical utility. In this case-control study, levels of 14-3-3 protein were evaluated in archival specimens from patients with JIA, systemic lupus erythematosus (SLE), and rheumatoid arthritis (RA), as well as healthy pediatric controls. Just over 200 patients were evaluated, using specimens banked between 1990 and 2011. Read More

View Article and Full-Text PDF
January 2021
Similar Publications

Concentration of survivin in children with oligo- and polyarticular juvenile idiopathic arthritis (JIA): diagnostic and prognostic value-a single-center study.

Authors:
Joanna Lipinska Marcin Kaszkowiak Beata Malachowska Joanna Swidrowska-Jaros Elzbieta Smolewska

Arthritis Res Ther 2021 01 26;23(1):40. Epub 2021 Jan 26.

Department of Pediatric Cardiology and Rheumatology, Medical University of Lodz, 36/50 Sporna St., 91-738, Lodz, Poland.

Aim: The goal of the study was to assess the diagnostic and prognostic utility of survivin in patients with juvenile idiopathic arthritis (JIA).

Methods: Seventy children with JIA-59 newly diagnosed and 11 biologically treated (46 girls and 17 boys) aged 1.5-18 years and 29 healthy children as a control group, appropriately matched in terms of sex and age, were included in the study. Read More

View Article and Full-Text PDF
January 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap